MX9201546A - USEFUL COMPOUNDS FOR THE TREATMENT OF HIV AND OTHER RETROVIRUSES. - Google Patents
USEFUL COMPOUNDS FOR THE TREATMENT OF HIV AND OTHER RETROVIRUSES.Info
- Publication number
- MX9201546A MX9201546A MX9201546A MX9201546A MX9201546A MX 9201546 A MX9201546 A MX 9201546A MX 9201546 A MX9201546 A MX 9201546A MX 9201546 A MX9201546 A MX 9201546A MX 9201546 A MX9201546 A MX 9201546A
- Authority
- MX
- Mexico
- Prior art keywords
- retroviruses
- hiv
- treatment
- useful compounds
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/6574—Esters of oxyacids of phosphorus
- C07F9/65742—Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67950891A | 1991-04-04 | 1991-04-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9201546A true MX9201546A (en) | 1993-02-01 |
Family
ID=24727186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9201546A MX9201546A (en) | 1991-04-04 | 1992-04-03 | USEFUL COMPOUNDS FOR THE TREATMENT OF HIV AND OTHER RETROVIRUSES. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0578745A1 (en) |
JP (1) | JPH06506463A (en) |
AU (1) | AU1748792A (en) |
MX (1) | MX9201546A (en) |
WO (1) | WO1992017490A1 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5643878A (en) * | 1991-09-12 | 1997-07-01 | Ciba-Geigy Corporation | 5-amino-4-hydroxyhexanoic acid derivatives |
US6825169B1 (en) | 1991-10-22 | 2004-11-30 | Trustees Of Tufts College | Inhibitors of dipeptidyl-aminopeptidase type IV |
DE69333270T2 (en) | 1992-03-11 | 2004-08-05 | Narhex Ltd. | AMINE DERIVATIVES OF OXO AND HYDROXY SUBSTITUTED CARBON HYDROGEN |
US6071895A (en) * | 1992-03-11 | 2000-06-06 | Narhex Limited | Polar-substituted hydrocarbons |
US5888992A (en) * | 1992-03-11 | 1999-03-30 | Narhex Limited | Polar substituted hydrocarbons |
WO1993018006A1 (en) * | 1992-03-11 | 1993-09-16 | Narhex Limited | Amine derivatives of oxo- and hydroxy-substitued hydrocarbons |
US5559256A (en) * | 1992-07-20 | 1996-09-24 | E. R. Squibb & Sons, Inc. | Aminediol protease inhibitors |
IL108459A0 (en) * | 1993-02-05 | 1994-04-12 | Opjohn Company | 4-Hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl [B] pyran-2-ones useful for treating infections due to hiv and other retroviruses |
IL129871A (en) * | 1994-05-06 | 2003-11-23 | Pharmacia & Upjohn Inc | Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections |
US5965532A (en) | 1996-06-28 | 1999-10-12 | Trustees Of Tufts College | Multivalent compounds for crosslinking receptors and uses thereof |
KR100447553B1 (en) | 1997-02-26 | 2004-09-08 | 화이자 인코포레이티드 | Heteroaryl-Hexanoic Acid Amide Derivative, Their Preparation and Their Use as Selective Inhibitor of MIP-1-Alpha Binding to its CCR1 Receptor |
US6040145A (en) | 1997-05-07 | 2000-03-21 | Tufts University | Potentiation of the immune response |
US6100234A (en) * | 1997-05-07 | 2000-08-08 | Tufts University | Treatment of HIV |
DE69837393T2 (en) | 1997-09-29 | 2007-12-06 | Point Therapeutics, Inc., Boston | STIMULATION OF HEMATOPOIETIC CELLS IN THE VITRO |
EA002822B1 (en) * | 1997-12-17 | 2002-10-31 | Мерк Энд Ко., Инк. | Integrin receptor antagonists |
NZ507730A (en) | 1998-05-04 | 2004-02-27 | Point Therapeutics Inc | Hematopoietic stimulation |
DK1084129T3 (en) | 1998-06-05 | 2003-05-19 | Point Therapeutics Inc | Cyclic boroProline Compounds |
US6890904B1 (en) | 1999-05-25 | 2005-05-10 | Point Therapeutics, Inc. | Anti-tumor agents |
AU2002245649A1 (en) * | 2001-03-02 | 2002-09-19 | Idun Pharmaceuticals, Inc. | Methods, compositions and kits for preserving antigenicity |
JP2005505517A (en) | 2001-07-10 | 2005-02-24 | イーラン ファーマスーティカルズ、インコーポレイテッド | Aminediol for the treatment of Alzheimer's disease |
-
1992
- 1992-03-27 JP JP4509356A patent/JPH06506463A/en active Pending
- 1992-03-27 AU AU17487/92A patent/AU1748792A/en not_active Abandoned
- 1992-03-27 EP EP92910121A patent/EP0578745A1/en not_active Withdrawn
- 1992-03-27 WO PCT/US1992/002238 patent/WO1992017490A1/en not_active Application Discontinuation
- 1992-04-03 MX MX9201546A patent/MX9201546A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1992017490A1 (en) | 1992-10-15 |
JPH06506463A (en) | 1994-07-21 |
EP0578745A1 (en) | 1994-01-19 |
AU1748792A (en) | 1992-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9201546A (en) | USEFUL COMPOUNDS FOR THE TREATMENT OF HIV AND OTHER RETROVIRUSES. | |
MX9204625A (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF A MAMMAL SPECIES, WHICH SUFFERS FROM CONGESTIVE HEART DEFICIENCY. | |
DE69230140T2 (en) | ANTIVIRAL NUCLEOSIDE COMBINATION | |
MX9204229A (en) | TRIFLUOROMETILBENCILFOSFONATOS USEFUL IN THE TREATMENT OF OSTEOPOROSIS. | |
DE69206378D1 (en) | Patient tables. | |
ES2174992T3 (en) | INTERMEDIATE PRODUCTS FOR THE OBTAINING OF INHIBITING COMPOUNDS OF RETROVIRAL PROTEASES. | |
ATE61582T1 (en) | STYRYLPYRAZOLE, -ISOXAZOLE AND ANALOGUES WITH 5LIPOXYGENASE INHIBITOR ACTIVITY AND PHARMACEUTICAL COMPOSITIONS THEREOF. | |
ES540645A0 (en) | APPARATUS FOR THE TREATMENT OF PLASMA. | |
ATE100098T1 (en) | NUCLEOSIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS. | |
ES2056180T3 (en) | NEW DERIVATIVES OF 2'-HALOMETILIDEN, 2'-ETENILIDEN AND 2'-ETINIL CITIDINA. | |
ES2038650T3 (en) | PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION INCLUDING 3'-DEOXYTIMIDIN-2'-ENO- (3'-DESOXI-2 ', 3'-DIDESHIDROTIMIDINA) TO TREAT PATIENTS INFECTED WITH RETROVIRUS. | |
SE9604348D0 (en) | Use of hydroxyguanidines | |
ATE71840T1 (en) | VIRUS INHIBITING NUCLEOSIDE MIXTURE. | |
ES2101747T3 (en) | PENCICLOVIR AND FAMCICLOVIR AND RELATED GUANINE DERIVATIVES FOR THE TREATMENT OF HIV-1 INFECTIONS. | |
MX9202507A (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF REFLUX ESOPHAGITIS. | |
MX9201258A (en) | COMPOUNDS FOR THE TREATMENT OF CANCER AND PROCEDURE FOR ITS PREPARATION. | |
SE9000624D0 (en) | NEW USE | |
IT8422384A0 (en) | TREATMENT OF ACQUIRED IMMUNODEFICIENCY SYNDROME. | |
NO934528L (en) | Acylated heparins as inhibitors of retroviral replication | |
DE3886155T2 (en) | Anthracycline derivatives with inhibitory activity against the reverse transcriptase of the human immunodeficiency virus. | |
SE8802040D0 (en) | NEW USE | |
NL7711777A (en) | BIOLOGICALLY ACTIVE TRICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN THOSE COMPOUNDS AS THE ACTIVE INGREDIENT. | |
MX9203715A (en) | PREPARATIONS FOR THE TREATMENT OF ALOINGERTADO TISSUE. | |
ES2019583B3 (en) | COMPOSITION FOR THE TREATMENT OF INFECTIONS. | |
BR9405887A (en) | Medicament for the treatment of retrovirus infections |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
MM | Annulment or lapse due to non-payment of fees |